Показано 0 из 0
Дата |
---|
20.05.2024 |
17.05.2024 |
16.05.2024 |
15.05.2024 |
14.05.2024 |
13.05.2024 |
10.05.2024 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
1.08
|
1.13
|
1.13
|
1.09
|
1.15
|
1.10
|
|
|
242 442.36
|
1 041.00
|
1.12
|
1.14
|
1.14
|
1.109
|
1.15
|
1.13
|
|
|
284 350.22
|
933.00
|
1.13
|
1.19
|
1.12
|
1.10
|
1.16
|
1.14
|
|
|
310 438.86
|
904.00
|
1.12
|
1.15
|
1.15
|
1.11
|
1.18
|
1.12
|
|
|
380 436.89
|
1 186.00
|
1.15
|
1.19
|
1.12
|
1.10
|
1.20
|
1.15
|
|
|
463 209.64
|
1 204.00
|
1.17
|
1.18
|
1.11
|
1.08
|
1.18
|
1.13
|
|
|
422 622.42
|
1 568.00
|
1.13
|
1.18
|
1.25
|
1.13
|
1.25
|
1.14
|
|
|
464 116.05
|
1 463.00
|
1.21
|
1.25
|
1.25
|
1.19
|
1.25
|
1.22
|
|
|
433 792.89
|
1 562.00
|
1.27
|
1.28
|
1.14
|
1.12
|
1.30
|
1.24
|
|
|
848 691.96
|
3 676.00
|
1.20
|
1.21
|
1.60
|
1.06
|
1.60
|
1.23
|
|
|
9 464 144.61
|
41 509.00
|
TC BioPharm is a privately-held, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious disease.